ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
|ICER's COO Participates in Roundtable at Arthritis Foundation Industry Summit|
ICER's COO, Sarah Emond, participated in a roundtable discussion "Comparative Effectiveness Research: What will this mean for patients, consumers, business and for the health care industry?" at the Arthritis Foundation Industry Summit on December 2, 2011.